A detailed history of Man Group PLC transactions in Inmune Bio, Inc. stock. As of the latest transaction made, Man Group PLC holds 24,388 shares of INMB stock, worth $139,499. This represents 0.0% of its overall portfolio holdings.

Number of Shares
24,388
Previous 40,549 39.86%
Holding current value
$139,499
Previous $476,000 54.83%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$7.15 - $11.84 $115,551 - $191,346
-16,161 Reduced 39.86%
24,388 $215,000
Q1 2024

May 15, 2024

BUY
$10.53 - $14.01 $262,144 - $348,778
24,895 Added 159.03%
40,549 $476,000
Q4 2023

Feb 14, 2024

BUY
$6.6 - $11.52 $103,316 - $180,334
15,654 New
15,654 $176,000

Others Institutions Holding INMB

About Inmune Bio, Inc.


  • Ticker INMB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 17,946,000
  • Market Cap $103M
  • Description
  • INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on developing drugs to reprogram the patient's innate immune system to treat disease. The company develops and commercializes product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation. Its development programs include INKmune, which focuses on tr...
More about INMB
Track This Portfolio

Track Man Group PLC Portfolio

Follow Man Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Man Group PLC with notifications on news.